PFIZER INC Payments to Acquire Marketable Securities
PFIZER INC (PFE) reported Payments to Acquire Marketable Securities of $95.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-04
- PFIZER INC payments to acquire marketable securities for the quarter ending 2026-06-28 was -$9.00M.
- PFIZER INC payments to acquire marketable securities for the quarter ending 2026-03-29 was $104.00M, a 22.39% decline year-over-year.
- PFIZER INC payments to acquire marketable securities for the quarter ending 2025-12-31 was $79.00M, a 24.76% decline year-over-year.
- PFIZER INC payments to acquire marketable securities for the quarter ending 2025-09-28 was $129.00M.
- PFIZER INC payments to acquire marketable securities for fiscal 2025 was $294.00M, a 63.33% increase from fiscal 2024.
- PFIZER INC payments to acquire marketable securities for fiscal 2024 was $180.00M, a 11.76% decline from fiscal 2023.
- PFIZER INC payments to acquire marketable securities for fiscal 2023 was $204.00M, a 89.34% decline from fiscal 2022.
- PFIZER INC payments to acquire marketable securities for fiscal 2022 was $1.91B, a 79.12% increase from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 9 month as first filed | Payments to Acquire Marketable Securities 12 month | Payments to Acquire Marketable Securities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-28 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $95.00M 10-Q · filed 2026-08-04 | $174.00M derived: sum of 3 quarters · filed 2026-08-04 | $303.00M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-29 | $104.00M 10-Q · filed 2026-05-05 | $183.00M derived: sum of 2 quarters · filed 2026-05-05 | $312.00M derived: sum of 3 quarters · filed 2026-05-05 | $264.00M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $208.00M derived: sum of 2 quarters · filed 2026-02-26 | $160.00M derived: sum of 3 quarters · filed 2026-08-04 | $294.00M 10-K · filed 2026-02-26 | ||
| 2025-09-28 | $129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $81.00M derived: sum of 2 quarters · filed 2026-08-04 | $215.00M 10-Q · filed 2025-11-04 | $320.00M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-29 | -$48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $86.00M 10-Q · filed 2026-08-04 | $191.00M derived: sum of 3 quarters · filed 2026-08-04 | $158.00M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-30 | $134.00M 10-Q · filed 2026-05-05 | $239.00M derived: sum of 2 quarters · filed 2026-05-05 | $206.00M derived: sum of 3 quarters · filed 2026-05-05 | $279.00M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $105.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $72.00M derived: sum of 2 quarters · filed 2026-02-26 | $145.00M derived: sum of 3 quarters · filed 2026-02-26 | $180.00M 10-K · filed 2026-02-26 | ||
| 2024-09-29 | -$33.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $40.00M derived: sum of 2 quarters · filed 2025-11-04 | $75.00M 10-Q · filed 2025-11-04 | $113.00M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $73.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $108.00M 10-Q · filed 2025-08-05 | $146.00M derived: sum of 3 quarters · filed 2026-02-26 | $220.00M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $35.00M 10-Q · filed 2025-05-05 | $73.00M derived: sum of 2 quarters · filed 2026-02-26 | $147.00M derived: sum of 3 quarters · filed 2026-02-26 | $188.00M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $112.00M derived: sum of 2 quarters · filed 2026-02-26 | $153.00M derived: sum of 3 quarters · filed 2026-02-26 | $204.00M 10-K · filed 2026-02-26 | ||
| 2023-10-01 | $74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $115.00M derived: sum of 2 quarters · filed 2024-11-04 | $166.00M 10-Q · filed 2024-11-04 | $452.00M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-07-02 | $41.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $92.00M 10-Q · filed 2024-08-05 | $378.00M derived: sum of 3 quarters · filed 2025-02-27 | $681.00M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-04-02 | $51.00M 10-Q · filed 2024-05-08 | $337.00M derived: sum of 2 quarters · filed 2025-02-27 | $640.00M derived: sum of 3 quarters · filed 2025-02-27 | $1.29B derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $286.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $589.00M derived: sum of 2 quarters · filed 2025-02-27 | $1.24B derived: sum of 3 quarters · filed 2025-02-27 | $1.91B 10-K · filed 2025-02-27 | ||
| 2022-10-02 | $303.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $951.00M derived: sum of 2 quarters · filed 2023-11-08 | $1.63B 10-Q · filed 2023-11-08 | $1.83B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-07-03 | $648.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.32B 10-Q · filed 2023-08-09 | $1.53B derived: sum of 3 quarters · filed 2024-02-22 | $2.29B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2022-04-03 | $676.00M 10-Q · filed 2023-05-10 | $883.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.64B derived: sum of 3 quarters · filed 2024-02-22 | $1.72B derived: sum of 4 quarters · filed 2024-02-22 | ||
| 2021-12-31 | $207.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $968.00M derived: sum of 2 quarters · filed 2024-02-22 | $1.04B derived: sum of 3 quarters · filed 2024-02-22 | $1.07B 10-K · filed 2024-02-22 | ||
| 2021-10-03 | $761.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $834.00M derived: sum of 2 quarters · filed 2022-11-09 | $861.00M 10-Q · filed 2022-11-09 | $1.17B derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-07-04 | $73.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $100.00M 10-Q · filed 2022-08-10 | $413.00M derived: sum of 3 quarters · filed 2023-02-23 | $529.00M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-04-04 | $27.00M 10-Q · filed 2022-05-11 | $340.00M derived: sum of 2 quarters · filed 2023-02-23 | $456.00M derived: sum of 3 quarters · filed 2023-02-23 | $602.00M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $313.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $429.00M derived: sum of 2 quarters · filed 2023-02-23 | $575.00M derived: sum of 3 quarters · filed 2023-02-23 | $597.00M 10-K · filed 2023-02-23 | ||
| 2020-09-27 | $116.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $262.00M derived: sum of 2 quarters · filed 2021-11-12 | $284.00M 10-Q · filed 2021-11-12 | $351.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $146.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $168.00M 10-Q · filed 2021-08-12 | $235.00M derived: sum of 3 quarters · filed 2022-02-24 | $246.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $22.00M 10-Q · filed 2021-05-13 | $89.00M derived: sum of 2 quarters · filed 2022-02-24 | $100.00M derived: sum of 3 quarters · filed 2022-02-24 | $139.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $78.00M derived: sum of 2 quarters · filed 2022-02-24 | $117.00M derived: sum of 3 quarters · filed 2022-02-24 | $201.00M 10-K · filed 2022-02-24 | ||
| 2019-09-29 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $50.00M derived: sum of 2 quarters · filed 2020-11-05 | $134.00M 10-Q · filed 2020-11-05 | $428.00M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $39.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $123.00M 10-Q · filed 2020-08-06 | $417.00M derived: sum of 3 quarters · filed 2021-02-25 | $850.00M derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $84.00M 10-Q · filed 2020-05-07 | $378.00M derived: sum of 2 quarters · filed 2021-02-25 | $811.00M derived: sum of 3 quarters · filed 2021-02-25 | $1.28B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $294.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $727.00M derived: sum of 2 quarters · filed 2021-02-25 | $1.19B derived: sum of 3 quarters · filed 2021-02-25 | $1.80B 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $433.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $898.00M derived: sum of 2 quarters · filed 2019-11-07 | $1.50B 10-Q · filed 2019-11-07 | $2.51B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-07-01 | $465.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.07B 10-Q · filed 2019-08-08 | $2.08B derived: sum of 3 quarters · filed 2020-02-27 | $2.94B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-04-01 | $605.00M 10-Q · filed 2019-05-09 | $1.62B derived: sum of 2 quarters · filed 2020-02-27 | $2.48B derived: sum of 3 quarters · filed 2020-02-27 | $3.40B derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $1.87B derived: sum of 2 quarters · filed 2020-02-27 | $2.80B derived: sum of 3 quarters · filed 2020-02-27 | $3.54B 10-K · filed 2020-02-27 | ||
| 2017-10-01 | $863.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.79B derived: sum of 2 quarters · filed 2018-11-08 | $2.53B 10-Q · filed 2018-11-08 | $5.77B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-07-02 | $923.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.66B 10-Q · filed 2018-08-09 | $4.90B derived: sum of 3 quarters · filed 2019-02-28 | $6.55B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-04-02 | $740.00M 10-Q · filed 2018-05-10 | $3.98B derived: sum of 2 quarters · filed 2019-02-28 | $5.63B derived: sum of 3 quarters · filed 2019-02-28 | $7.44B derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $3.24B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.88B derived: sum of 2 quarters · filed 2019-02-28 | $6.70B derived: sum of 3 quarters · filed 2019-02-28 | $8.01B 10-K · filed 2019-02-28 | ||
| 2016-10-02 | $1.65B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.46B derived: sum of 2 quarters · filed 2017-11-09 | $4.77B 10-Q · filed 2017-11-09 | $7.74B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $1.82B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $3.13B 10-Q · filed 2017-08-10 | $6.09B derived: sum of 3 quarters · filed 2018-02-22 | $7.25B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | $1.31B 10-Q · filed 2017-05-11 | $4.27B derived: sum of 2 quarters · filed 2018-02-22 | $5.43B derived: sum of 3 quarters · filed 2018-02-22 | $7.70B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2015-12-31 | $2.96B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $4.12B derived: sum of 2 quarters · filed 2018-02-22 | $6.39B derived: sum of 3 quarters · filed 2018-02-22 | $9.54B 10-K · filed 2018-02-22 | ||
| 2015-09-27 | $1.16B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $3.43B derived: sum of 2 quarters · filed 2016-11-10 | $6.58B 10-Q · filed 2016-11-10 | $8.04B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-06-28 | $2.27B derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $5.42B 10-Q · filed 2016-08-11 | $6.89B derived: sum of 3 quarters · filed 2017-02-23 | $10.81B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-29 | $3.15B 10-Q · filed 2016-05-12 | $4.61B derived: sum of 2 quarters · filed 2017-02-23 | $8.54B derived: sum of 3 quarters · filed 2017-02-23 | $12.06B derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $5.39B derived: sum of 2 quarters · filed 2017-02-23 | $8.91B derived: sum of 3 quarters · filed 2017-02-23 | $10.72B 10-K · filed 2017-02-23 | ||
| 2014-09-28 | $3.93B derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $7.45B derived: sum of 2 quarters · filed 2015-11-05 | $9.25B 10-Q · filed 2015-11-05 | $11.53B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-29 | $3.52B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $5.33B 10-Q · filed 2015-08-06 | $7.60B derived: sum of 3 quarters · filed 2016-02-29 | $11.11B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-30 | $1.81B 10-Q · filed 2015-05-07 | $4.08B derived: sum of 2 quarters · filed 2016-02-29 | $7.59B derived: sum of 3 quarters · filed 2016-02-29 | $10.58B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $2.27B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.79B derived: sum of 2 quarters · filed 2016-02-29 | $8.77B derived: sum of 3 quarters · filed 2016-02-29 | $11.02B 10-K · filed 2016-02-29 | ||
| 2013-09-29 | $3.51B derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $6.50B derived: sum of 2 quarters · filed 2014-11-06 | $8.75B 10-Q · filed 2014-11-06 | $11.20B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $2.99B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.23B 10-Q · filed 2014-08-07 | $7.68B derived: sum of 3 quarters · filed 2015-02-27 | $14.06B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $2.25B 10-Q · filed 2014-05-08 | $4.70B derived: sum of 2 quarters · filed 2015-02-27 | $11.07B derived: sum of 3 quarters · filed 2015-02-27 | $12.21B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $2.45B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.83B derived: sum of 2 quarters · filed 2015-02-27 | $9.96B derived: sum of 3 quarters · filed 2015-02-27 | $11.14B 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $6.38B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $7.51B derived: sum of 2 quarters · filed 2013-11-08 | $8.69B 10-Q · filed 2013-11-08 | $9.67B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $1.13B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.32B 10-Q · filed 2013-08-09 | $3.29B derived: sum of 3 quarters · filed 2014-02-28 | $3.74B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | $1.18B 10-Q · filed 2013-05-10 | $2.16B derived: sum of 2 quarters · filed 2014-02-28 | $2.61B derived: sum of 3 quarters · filed 2014-02-28 | $3.87B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2011-12-31 | $974.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.43B derived: sum of 2 quarters · filed 2014-02-28 | $2.69B derived: sum of 3 quarters · filed 2014-02-28 | $4.62B 10-K · filed 2014-02-28 | $4.06B 10-K · filed 2012-02-28 | |
| 2011-10-02 | $453.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.71B derived: sum of 2 quarters · filed 2012-11-09 | $3.65B 10-Q · filed 2012-11-09 | $3.45B 10-Q · filed 2011-11-10 | $5.10B derived: sum of 4 quarters · filed 2013-02-28 | |
| 2011-07-03 | $1.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $3.19B 10-Q · filed 2012-08-09 | $4.65B derived: sum of 3 quarters · filed 2013-02-28 | $5.84B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-04-03 | $1.93B 10-Q · filed 2012-05-10 | $3.39B derived: sum of 2 quarters · filed 2013-02-28 | $4.58B derived: sum of 3 quarters · filed 2013-02-28 | $5.20B derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2010-12-31 | $1.45B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.65B derived: sum of 2 quarters · filed 2013-02-28 | $3.27B derived: sum of 3 quarters · filed 2013-02-28 | $4.13B 10-K · filed 2013-02-28 | $3.92B 10-K · filed 2011-02-28 | |
| 2010-10-03 | $1.19B derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $1.82B derived: sum of 2 quarters · filed 2011-11-10 | $2.67B 10-Q · filed 2011-11-10 | $3.51B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-07-04 | $623.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $1.48B 10-Q · filed 2011-08-11 | $2.32B derived: sum of 3 quarters · filed 2012-02-28 | $3.10B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-04-04 | $858.00M 10-Q · filed 2011-05-12 | $1.69B derived: sum of 2 quarters · filed 2012-02-28 | $2.48B derived: sum of 3 quarters · filed 2012-02-28 | $4.30B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2009-12-31 | $835.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $1.62B derived: sum of 2 quarters · filed 2012-02-28 | $3.45B derived: sum of 3 quarters · filed 2012-02-28 | $6.89B 10-K · filed 2012-02-28 | ||
| 2009-09-27 | $787.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | $2.61B derived: sum of 2 quarters · filed 2010-11-12 | $6.05B 10-Q · filed 2010-11-12 | $10.12B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-28 | $1.82B derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $5.27B 10-Q · filed 2010-08-12 | $9.33B derived: sum of 3 quarters · filed 2011-02-28 | $10.77B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-29 | $3.44B 10-Q · filed 2010-05-13 | $7.51B derived: sum of 2 quarters · filed 2011-02-28 | $8.94B derived: sum of 3 quarters · filed 2011-02-28 | |||
| 2008-12-31 | $4.07B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $5.50B derived: sum of 2 quarters · filed 2011-02-28 | $9.36B 10-K · filed 2011-02-28 | |||
| 2008-09-28 | $1.44B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $5.29B 10-Q · filed 2009-11-05 | ||||
| 2008-06-29 | $3.86B 10-Q · filed 2009-08-06 | |||||
| 2007-12-31 | $1.64B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |